# Safety Study of ISIS 325568 in Healthy Volunteers

> **NCT00519727** · PHASE1 · COMPLETED · sponsor: **Ionis Pharmaceuticals, Inc.** · enrollment: 60 (estimated)

## Conditions studied

- Type 2 Diabetes Mellitus

## Interventions

- **DRUG:** ISIS 325568

## Key facts

- **NCT ID:** NCT00519727
- **Lead sponsor:** Ionis Pharmaceuticals, Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2007-08
- **Primary completion:** 2008-04
- **Final completion:** 2008-06
- **Target enrollment:** 60 (ESTIMATED)
- **Last updated:** 2008-08-19


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00519727

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00519727, "Safety Study of ISIS 325568 in Healthy Volunteers". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT00519727. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*